Malic acid

CAS No. 6915-15-7

Malic acid( E 296 | FDA 2018 | Hydroxybutanedioic acid )

Catalog No. M19003 CAS No. 6915-15-7

Malic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 35 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Malic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Malic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.
  • Description
    Malic acid did reduce populations of L. monocytogenes on poultry. Malic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    E 296 | FDA 2018 | Hydroxybutanedioic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    6915-15-7
  • Formula Weight
    134.08
  • Molecular Formula
    C4H6O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (745.77 mM)
  • SMILES
    C(C(C(=O)O)O)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Gatipotuzumab

    Gatipotuzumab (PankoMab) is a novel humanized monoclonal antibody conjugated to the tumor-associated epitope of mucin 1 (TA-MUC1) with potential anti-tumor activity for the study of recurrent epithelial ovarian cancer.

  • (2E)-N-(4-methoxyphe...

    (2E)-N-(4-methoxyphenyl)-3-[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]prop-2-enamide is a compound used as a molecular building block.

  • Indecainide

    Indecainide (Ricainid) is a novel antiarrhythmic compound that is carcinogenic and can be used to study chronic stable ventricular arrhythmias secondary to coronary artery disease or cardiomyopathy.